CRISPR Therapeutics AG

CRSP · XNAS

CIK 1674416fmd_1P4Z68KQ4HJ7G7B6WN1NKPHAB1Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2014 to Sep 30, 2026, 48 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.